Invest in TTC Oncology on Wefunder
Health & WellnessTech
Women

TTC Oncology

TTC Oncology developed TTC-352, a small molecule to fight breast cancer.
Minneapolis, 
MN
Investment type:
Equity
(SAFE)
Target raise:
$50,000
 - $250,000
Minimum investment:​
$100
End date:
Jan 01, 2023
ended
Highlights

  • Novel mechanism of action therapy for hormone resistant of breast cancer.
  • Intellectual property protected until 2033.
  • Safe and well tolerated oral capsule therapy.
  • Biomarker that identifies breast cancer that will respond well to TTC-352.
Our Story

We have developed new treatment for breast cancer.
Our Ambition

We would like to have our drug, TTC-352 available in pharmacies to help women with breast cancer.